American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: controlling tuberculosis in the United States - PubMed (original) (raw)
Practice Guideline
. 2005 Nov 1;172(9):1169-227.
doi: 10.1164/rccm.2508001.
- PMID: 16249321
- DOI: 10.1164/rccm.2508001
Practice Guideline
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: controlling tuberculosis in the United States
American Thoracic Society et al. Am J Respir Crit Care Med. 2005.
Abstract
During 1993-2003, incidence of tuberculosis (TB) in the United States decreased 44% and is now occurring at a historic low level (14,874 cases in 2003). The Advisory Council for the Elimination of Tuberculosis has called for a renewed commitment to eliminating TB in the United States, and the Institute of Medicine has published a detailed plan for achieving that goal. In this statement, the American Thoracic Society (ATS), Centers for Disease Control and Prevention (CDC), and the Infectious Diseases Society of America (IDSA) propose recommendations to improve the control and prevention of TB in the United States and to progress toward its elimination. This statement is one in a series issued periodically by the sponsoring organizations to guide the diagnosis, treatment, control, and prevention of TB. This statement supersedes the previous statement by ATS and CDC, which was also supported by IDSA and the American Academy of Pediatrics (AAP). This statement was drafted, after an evidence-based review of the subject, by a panel of representatives of the three sponsoring organizations. AAP, the National Tuberculosis Controllers Association, and the Canadian Thoracic Society were also represented on the panel. This statement integrates recent scientific advances with current epidemiologic data, other recent guidelines from this series, and other sources into a coherent and practical approach to the control of TB in the United States. Although drafted to apply to TB-control activities in the United States, this statement might be of use in other countries in which persons with TB generally have access to medical and public health services and resources necessary to make a precise diagnosis of the disease; achieve curative medical treatment; and otherwise provide substantial science-based protection of the population against TB. This statement is aimed at all persons who advocate, plan, and work at controlling and preventing TB in the United States, including persons who formulate public health policy and make decisions about allocation of resources for disease control and health maintenance and directors and staff members of state, county, and local public health agencies throughout the United States charged with control of TB. The audience also includes the full range of medical practitioners, organizations, and institutions involved in the health care of persons in the United States who are at risk for TB.
Comment in
- Failure to mention fixed-dose drug combinations in the ATS/CDC/IDSA tuberculosis control statement.
Moulding T. Moulding T. Am J Respir Crit Care Med. 2006 Mar 15;173(6):684; author reply 684-5. doi: 10.1164/ajrccm.173.6.684. Am J Respir Crit Care Med. 2006. PMID: 16522766 No abstract available.
Similar articles
- Diagnosis, Treatment, and Prevention of Tuberculosis Among People Experiencing Homelessness in the United States: Current Recommendations.
Marks SM, Self JL, Venkatappa T, Wolff MB, Hopkins PB, Augustine RJ, Khan A, Schwartz NG, Schmit KM, Morris SB. Marks SM, et al. Public Health Rep. 2023 Nov-Dec;138(6):896-907. doi: 10.1177/00333549221148173. Epub 2023 Jan 26. Public Health Rep. 2023. PMID: 36703605 Review. - Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America.
Taylor Z, Nolan CM, Blumberg HM; American Thoracic Society; Centers for Disease Control and Prevention; Infectious Diseases Society of America. Taylor Z, et al. MMWR Recomm Rep. 2005 Nov 4;54(RR-12):1-81. MMWR Recomm Rep. 2005. PMID: 16267499 - Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC.
National Tuberculosis Controllers Association; Centers for Disease Control and Prevention (CDC). National Tuberculosis Controllers Association, et al. MMWR Recomm Rep. 2005 Dec 16;54(RR-15):1-47. MMWR Recomm Rep. 2005. PMID: 16357823 - Tuberculosis.
Bloom BR, Atun R, Cohen T, Dye C, Fraser H, Gomez GB, Knight G, Murray M, Nardell E, Rubin E, Salomon J, Vassall A, Volchenkov G, White R, Wilson D, Yadav P. Bloom BR, et al. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. PMID: 30212088 Free Books & Documents. Review.
Cited by
- WHO's end of TB targets: unachievable by 2035 without addressing under nutrition, forced displacement, and homelessness: trend analysis from 2015 to 2022.
Ayenew B, Belay DM, Gashaw Y, Gimja W, Gardie Y. Ayenew B, et al. BMC Public Health. 2024 Apr 4;24(1):961. doi: 10.1186/s12889-024-18400-5. BMC Public Health. 2024. PMID: 38575958 Free PMC article. - Biosensors; nanomaterial-based methods in diagnosing of Mycobacterium tuberculosis.
Mobed A, Darvishi M, Kohansal F, Dehfooli FM, Alipourfard I, Tahavvori A, Ghazi F. Mobed A, et al. J Clin Tuberc Other Mycobact Dis. 2023 Dec 25;34:100412. doi: 10.1016/j.jctube.2023.100412. eCollection 2024 Feb. J Clin Tuberc Other Mycobact Dis. 2023. PMID: 38222862 Free PMC article. Review. - Efficacy of LAMP assay for Mycobacterial spp. detection to prevent treatment delays and onset of drug resistance: a systematic review and meta-analysis.
Bumbrah GS, Jain S, Fatima Z, Hameed S. Bumbrah GS, et al. Drug Target Insights. 2023 Jun 7;17:78-89. doi: 10.33393/dti.2023.2596. eCollection 2023 Jan-Dec. Drug Target Insights. 2023. PMID: 37304408 Free PMC article. Review. - Diagnosis, Treatment, and Prevention of Tuberculosis Among People Experiencing Homelessness in the United States: Current Recommendations.
Marks SM, Self JL, Venkatappa T, Wolff MB, Hopkins PB, Augustine RJ, Khan A, Schwartz NG, Schmit KM, Morris SB. Marks SM, et al. Public Health Rep. 2023 Nov-Dec;138(6):896-907. doi: 10.1177/00333549221148173. Epub 2023 Jan 26. Public Health Rep. 2023. PMID: 36703605 Review. - Mycobacterial infections in solid organ transplant recipients.
Rashid HU, Begum NAS, Kashem TS. Rashid HU, et al. Korean J Transplant. 2021 Dec 31;35(4):208-217. doi: 10.4285/kjt.21.0033. Korean J Transplant. 2021. PMID: 35769848 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous